PHK
BIO icon

Point72 Hong Kong’s Bio-Rad Laboratories Class A BIO Stock Holding History

Point72 Hong Kong’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-600
Closed -$448K – 1899
2021
Q3 		$448K Buy
+600
New +$449K 0.01% 952

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
FPA
First Pacific Advisors El Segundo, California $7.14B AUM 21.51% 1-Year Est. Return

Point72 Hong Kong's BIO Position: Q2 2025 in Review

Point72 Hong Kong sold out of Bio-Rad Laboratories Class A (BIO) in Q2 2025, closing a stake of 286 shares — an estimated $69.7K sold.

Point72 Hong Kong first reported a position in BIO in Q2 2015 and held it in 18 quarters. The position peaked at $7.27M in Q4 2023. 384 funds tracked by Wall St. Rank hold BIO as of Q2 2025.

  • Point72 Hong Kong reported no remaining Bio-Rad Laboratories Class A position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 286 Bio-Rad Laboratories Class A shares in Q2 2025, an estimated $69.7K.
  • Point72 Hong Kong first reported a position in Bio-Rad Laboratories Class A in Q2 2015 and held it in 18 quarters.
  • Point72 Hong Kong's Bio-Rad Laboratories Class A position peaked at $7.27M in Q4 2023.
  • 384 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.